НовостиBenzingaWedbush Maintains Outperform on BridgeBio Oncology, Lowers Price Target to $9 Wedbush Maintains Outperform on BridgeBio Oncology, Lowers Price Target to $9 Benzinga 2026.11.11 14:15 (GMT+0) Открыть на Benzinga Другие новости